Form 4 for IT Gartner
Accepted 2023-11-15 00:00:00 ET · period of report 2023-11-13 · accession 0001127602-23-027445 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-15 | 2023-11-13 | IT | Dawkins Alwyn | EVP, Gbl Business Sales | M - OptEx | $114.26 | +11.0K | 53.9K | +25% | +$1.25M |
| D | 2023-11-15 | 2023-11-13 | IT | Dawkins Alwyn | EVP, Gbl Business Sales | D - Sale to Iss | $414.50 | -3,021 | 50.9K | -6% | -$1.25M |
| D | 2023-11-15 | 2023-11-13 | IT | Dawkins Alwyn | EVP, Gbl Business Sales | F - Tax | $414.50 | -3,123 | 47.8K | -6% | -$1.29M |
| D | 2023-11-15 | 2023-11-13 | IT | Dawkins Alwyn | EVP, Gbl Business Sales | M - OptEx | $0.00 | -11.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-13 | M | A | 10,958 | $114.26 | 53,931 | D | — | — | (F1) Represents shares acquired upon exercise of SARs. |
| 2 | Common | Common Stock | 2023-11-13 | D | D | 3,021 | $414.50 | 50,910 | D | — | — | (F2) Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs. |
| 3 | Common | Common Stock | 2023-11-13 | F | D | 3,123 | $414.50 | 47,787 | D | — | — | (F3) Represents shares withheld for the payment of applicable income and payroll withholding taxes. |
| 4 | Derivative | Stock Appreciation Rights | 2023-11-13 | M | D | 10,958 | $0.00 | 0 | D | $114.26 · 2019-02-08 to 2025-02-08 | 10,958 Common Stock | (F4) These SARS are part of an award that became exercisable in four substantially equal annual installments, commencing on February 8, 2019 and are fully exercisable. |